Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2
It is not available as a prescribed or compounded medication, and its use is restricted to research settings governed by applicable institutional and regulatory frameworks
GHK-Cu: Injectable formulations are now on the FDA's Category 2 bulk drug substances list as of 2026, meaning compounding pharmacies cannot legally compound it for injection
Patients may receive weekly or bi-weekly injections, but this can be adjusted based on your response and goals
Bridging the gap between research, healthcare professionals, and patients is crucial for a more cohesive and supportive approach to managing B12 deficiency
Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach
US$ 23.87
US$ 29.72
US$ 25.91
